Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Mar
23
Today In Oncology
Study Finds Inferior Survival Among Black Patients With AML, Independent of Cytogenetic Risk
Lisocabtagene Maraleucel in Relapsed or Refractory MZL
Dietary Influence on Leukemia and Lymphoma Progression
Three AI-Enabled Analyses Highlight Context-Dependent Biomarkers in Early-Onset Colorectal Cancer
Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo